Michael Exton

Michael Exton

Chief Executive Officer at LEXICON PHARMACEUTICALS, INC.

Net worth: 716 237 $ as of 29/06/2026

56 year
Health Technology
Consumer Services

Profile

Dr. Michael Exton is a Chief Executive Officer & Director at Lexicon Pharmaceuticals, Inc. He is on the Board of Directors at Lexicon Pharmaceuticals, Inc. Dr. Exton was previously employed as a Head-Cardiometabolic Therapeutic by Novartis AG, a Vice President & Head-Cardiovascular Renal by Novartis, Inc., and a Director-Business Development by Invida Group Pte Ltd. He received his undergraduate degree from The University of Newcastle, a doctorate degree from The University of Newcastle and a doctorate degree from the University of Duisburg-Essen.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
05/03/2026 298,432 ( 0.07% ) 716 237 $ 29/06/2026

Michael Exton active positions

CompaniesPositionStart
LEXICON PHARMACEUTICALS, INC. Chief Executive Officer 07/07/2024

Former positions of Michael Exton

CompaniesPositionEnd
NOVARTIS AG Corporate Officer/Principal 31/05/2024
Corporate Officer/Principal 31/07/2022
Corporate Officer/Principal 31/08/2010
See the detail of Michael Exton's experience

Training of Michael Exton

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

62

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology